Recent initiatives at King Daughter’s Medical Center
have helped in improving the process of history reconciliation within medicine.
The medical center is attempting to develop a resilient system for analyzing
healthcare records. Meanwhile, inaccuracy of medical records is a matter of
concern for the medical industry. Furthermore, incomplete medical data can be a
deadlock in diagnosis, treatment, and analysis of patients. Electronic health
records (EHRs) from multiple sources can exhibit deviant patterns related to
name and information of patient. Additionally, the nomenclature of EHRs is the
most challenging task within medical history reconciliation. Different systems
use different conventions for nomenclature’s, and they often fail to translate
Elucidating Errors in EHR
King Daughter’s Medical Center is focusing on
improving this system to foster precision in healthcare and medicine. Missing
data, or sigs, can pose severe problems for patients and medical practitioners.
To exemplify, the system often fails to differentiate between 1.0 mg and 10 mg
doses. Furthermore, the problem of mixing hourly doses with bedtime or daily
dosage is also a challenge within EHRs. Inaccuracy of medication can be a major
contributor to post-discharge adverse drug reactions. Clinical staff and
pharmacists from King Daughter’s were subjected to a range of workflow
challengeS. They tried to deal with sigs manually, and this helped them in
developing automated transcription. Manual ascertaining of sigs is a
time-consuming process that is subject to human errors.
Solution Proposed by the Center
Following this, Researchers from King Daughter’s
Medical Center proposed a system to digitize records. In addition, they propose
to convert free-text into automated systems that processes results according to
hospital nomenclature. This would in turn help in filling the missing gaps and
disruptions in medical workflows. It would be interesting to see the adoption
rate of the system proposed by King’s Daughter Medical Center. Several
improvements in EHRs have made their way in to the healthcare sector in recent
The drive for sharps containers stemmed from the adoption of safe and environmentally friendly ways of waste disposal in the healthcare industry. World over, such practices have gathered traction, especially in emerging economies. These geographies have been witnessing substantial advances in their medical infrastructure. The sharps containers market has also gathered a marked impetus from numerous countries increasingly focusing on adopting hazard disposal practices. The initiatives are helping them comply with pharmaceutical regulations.
Get Sample Copy of this Report @
awareness of the need for proper waste disposal practice among clinicians and
healthcare staff reduce the risk of injury as well as infections from sharps,
including contaminated needles and syringes. Sharps containers have been
playing a crucial role here. Growing incidence of needle-stick injuries in
various healthcare settings has bolstered the demands for sharps containers. Recently,
as homecare is making notable strides, the use of sharps containers among caregivers
at home settings will witness a significant growth. The trend will boost the
prospects in the sharps containers market.
Biodegradable Materials for Containers Make
Manufacturers Environmentally Responsible
Over the past few years, manufacturers in the sharps containers market have been unveiling products that are autoclave and incinerator-safe. This will go a long way to ensuring that waste disposable processes should also be environmentally friendly and sustainable. They have also benefitted from the advent of better puncture-resistant materials with low environmental footprint. An example is sharps containers made of biodegradable materials, which is expected to attract large numbers of big manufacturers focusing on developed and developing markets.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6179
sharps disposal containers by regulatory agencies has been a key factor
boosting the attractiveness quotient of these products, especially in developed
economies. A case in point is FDA-cleared sharps containers. The advent of
containers that are easy to operate has also fueled their consumption in key
healthcare markets around the world.
Researchers have developed a new method to
enhance the healing power of the heart post a heart-attack. The research was
conducted by the Westmead Institute for Medical Research (WIMR), in
collaboration with the University of Sydney. The researchers point to the
ability of protein therapy, involving human platelets, as a sound contributor
to healing. Use of recombinant human platelet-derived growth factor-AB
(rhPDGF-AB) could enhance outcomes following heart attacks. The findings of the
research open new avenues for advancements within the field of cardiology. Science
Translational Medicine journal published the findings of the research.
Development and Effect of Scar Tissues
Scar tissues formed after a heart attack
adversely affect the functioning of the heart. Meanwhile, researchers assert
that infusion of rhPDGF-AB could help in improving the quality of the scar.
Furthermore, this also induces the development of fresh blood vessels in the
heart. The risk of heart arrhythmia can be reduced through infusion of
rhPDGF-AB in the body. Patients suffering from heart arrhythmia experience
irregular heart rhythms, and this can be fatal in the long-run.
The lead researcher states unavailability
of treatment for scars developed after a heart attack. The research in question
is in the pre-clinical stage, and could be the first to impact scar health. The
researchers explain that improvements in cardiac function and scar health could
increase survival rate during heart attacks.
Increasing Strength of Scars
During research, infusion of rhPDGF-AB did not
increase the size of scar. However, it did cause the scar to undergo fiber
alignment and acquire greater strength. These changes led to improvements in
heart functionality, and subsequently accelerated the process of healing.
Researchers used mouse models to show improvements in heart help through
protein therapy. They claim to have compelling data to prove the veracity of